MGS Launches Hybrid Tooling to Accelerate Global Healthcare Product Development

MGS expands hybrid tooling globally, enabling faster injection-molded prototyping, earlier validation, and reduced manufacturing risk. New capability helps healthcare innovators validate designs under production-like conditions before committing to full production tooling. As healthcare products become more complex and development timelines continue to accelerate, manufacturers are under growing pressure to validate designs earlier while reducing downstream production risk. Responding to this need with greater speed, confidence and manufacturing insight, MGS, a global healthcare contract development and manufacturing organization (CDMO), has expanded its hybrid tooling capability globally following successful implementation alongside the company’s A.i.r. Platform™ . Designed to streamline the transition from…

Source: Medical Device Network